Immediate Impact
3 from Science/Nature 59 standout
Citing Papers
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Lara Dunn being referenced
innovaTV 207: New combination dosing cohorts in the open label phase 2 study of tisotumab vedotin in solid tumors.
2022
A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC).
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lara Dunn | 868 | 436 | 422 | 555 | 87 | 1.7k | |
| Sze Huey Tan | 820 | 389 | 319 | 347 | 82 | 1.7k | |
| Wen-Fei Li | 887 | 987 | 576 | 649 | 62 | 1.9k | |
| Yuan Zhang | 603 | 745 | 304 | 444 | 71 | 1.4k | |
| Robert E. Wittes | 916 | 175 | 378 | 463 | 42 | 2.0k | |
| Ethan B. Ludmir | 770 | 96 | 700 | 557 | 189 | 2.0k | |
| Cheng Xu | 877 | 314 | 461 | 339 | 101 | 1.7k | |
| A. Hartley | 814 | 702 | 506 | 847 | 67 | 1.8k | |
| Nicole G. Chau | 1224 | 468 | 439 | 758 | 79 | 2.2k | |
| Sungjin Kim | 585 | 396 | 624 | 546 | 86 | 1.8k | |
| Ilaria Girolami | 525 | 100 | 425 | 232 | 76 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...